1
|
Little RB, Carter SJ, Motl RW, Hunter G, Cook A, Liu N, Krontiras H, Lefkowitz EJ, Turan B, Schleicher E, Rogers LQ. Role of Gut Microbe Composition in Psychosocial Symptom Response to Exercise Training in Breast Cancer Survivors (ROME) study: protocol for a randomised controlled trial. BMJ Open 2024; 14:e081660. [PMID: 38702085 PMCID: PMC11086582 DOI: 10.1136/bmjopen-2023-081660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2023] [Accepted: 04/12/2024] [Indexed: 05/06/2024] Open
Abstract
INTRODUCTION Breast cancer survivors have an increased risk for chronic fatigue and altered gut microbiota composition, both with negative health and quality of life affects. Exercise modestly improves fatigue and is linked to gut microbial diversity and production of beneficial metabolites. Studies suggest that gut microbiota composition is a potential mechanism underlying fatigue response to exercise. Randomised controlled trials testing the effects of exercise on the gut microbiome are limited and there is a scarcity of findings specific to breast cancer survivors. The objective of this study is to determine if fitness-related modifications to gut microbiota occur and, if so, mediate the effects of aerobic exercise on fatigue response. METHODS AND ANALYSIS The research is a randomised controlled trial among breast cancer survivors aged 18-74 with fatigue. The primary aim is to determine the effects of aerobic exercise training compared with an attention control on gut microbiota composition. The secondary study aims are to test if exercise training (1) affects the gut microbiota composition directly and/or indirectly through inflammation (serum cytokines), autonomic nervous system (heart rate variability) or hypothalamic-pituitary-adrenal axis mediators (hair cortisol assays), and (2) effects on fatigue are direct and/or indirect through changes in the gut microbiota composition. All participants receive a standardised controlled diet. Assessments occur at baseline, 5 weeks, 10 weeks and 15 weeks (5 weeks post intervention completion). Faecal samples collect the gut microbiome and 16S gene sequencing will identify the microbiome. Fatigue is measured by a 13-item multidimensional fatigue scale. ETHICS AND DISSEMINATION The University of Alabama at Birmingham Institutional Review Board (IRB) approved this study on 15 May 2019, UAB IRB#30000320. A Data and Safety Monitoring Board convenes annually or more often if indicated. Findings will be disseminated in peer-reviewed journals and conference presentations. TRIAL REGISTRATION NUMBER ClinicalTrials.gov, NCT04088708.
Collapse
Affiliation(s)
- Rebecca B Little
- Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Stephen J Carter
- Department of Kinesiology, Indiana University Bloomington, Bloomington, Indiana, USA
| | - Robert W Motl
- Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, Illinois, USA
| | - Gary Hunter
- Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Abby Cook
- Baylor Scott & White Medical Center Temple, Temple, Texas, USA
| | - Nianjun Liu
- Department of Epidemiology and Biostatistics, Indiana University Bloomington, Bloomington, Indiana, USA
| | - Helen Krontiras
- Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Elliot J Lefkowitz
- Department of Computer Science, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Bulent Turan
- Department of Psychology, Koc University, Istanbul, Turkey
| | - Erica Schleicher
- Department of Health Behavior, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Laura Q Rogers
- Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
| |
Collapse
|
2
|
Schleicher E, McAuley E, Courneya KS, Anton P, Ehlers DK, Phillips SM, Brown NI, Oster RA, Pekmezi D, Rogers LQ. Breast cancer survivors' exercise preferences change during an exercise intervention are associated with post-intervention physical activity. J Cancer Surviv 2023:10.1007/s11764-023-01389-y. [PMID: 37120460 DOI: 10.1007/s11764-023-01389-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2023] [Accepted: 04/19/2023] [Indexed: 05/01/2023]
Abstract
PURPOSE Exercise program preferences are important for designing physical activity (PA) interventions; yet may change following an intervention. Further, the relationship between preferences and PA behavior change is unclear. This study evaluated exercise program preferences among breast cancer survivors (BCS) before and after a behavioral intervention and associations between program preferences and PA change. METHODS BCS were randomized to the BEAT Cancer intervention (n = 110) or written materials (n = 112). Questionnaires assessed exercise program preferences. Minutes per week of moderate-to-vigorous PA (MVPA) were accelerometer-measured and self-reported at baseline (M0), post-intervention (M3), and 3-month follow-up (M6). RESULTS At M0, the majority of intervention group participants preferred exercising with others (62%) yet shifted to preferring exercising alone (59%) at M3 (p < 0.001). Furthermore, preferring exercising with others at M0 was associated with greater increases in self-reported MVPA between M0 and M6 (124.2 ± 152 vs. 53.1 ± 113.8, p = 0.014). BCS preferring facility-based exercise decreased after the BEAT Cancer intervention (14% vs. 7%, p = 0.039) and preferring exercising at home/had no preference at M0 had greater improvements in accelerometer-measured MVPA from M0 to M3 (74.3 ± 118.8 vs. -2.3 ± 78.4, p = 0.033) and M0 to M6 (44.9 ± 112.8 vs. 9.3 ± 30.4, p = 0.021). Exercise program preferences regarding mode of counseling, training supervision, and type of exercise changed from M0 to M3 but were not associated with changes in MVPA. CONCLUSION Findings suggest BCS exercise program preferences may change after an intervention and be associated with changes in MVPA. Understanding the role of PA preferences will better inform the design and success of PA behavior change interventions. ClinicTrials.gov, ClinicalTrials.gov number: NCT00929617.
Collapse
Affiliation(s)
- Erica Schleicher
- Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.
- O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL, USA.
| | - Edward McAuley
- Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL, USA
- The Cancer Center at Illinois, Urbana, IL, USA
| | - Kerry S Courneya
- Faculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, AB, Canada
| | - Philip Anton
- School of Human Sciences, Southern Illinois University Carbondale, Carbondale, IL, USA
| | - Diane K Ehlers
- Division of Epidemiology, Mayo Clinic, Scottsdale, AZ, USA
| | - Siobhan M Phillips
- Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Nashira I Brown
- Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Robert A Oster
- O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL, USA
- Division of Preventive Medicine, Department of Medicine, Birmingham, AL, USA
| | - Dorothy Pekmezi
- Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA
- O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL, USA
| | - Laura Q Rogers
- O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL, USA
- Division of Preventive Medicine, Department of Medicine, Birmingham, AL, USA
| |
Collapse
|
3
|
Schleicher E, McAuley E, Courneya KS, Anton P, Ehlers DK, Phillips SM, Brown NI, Oster RA, Pekmezi D, Rogers LQ. Breast Cancer Survivors' Exercise Preferences Change During an Exercise Intervention and are associated with Post-Intervention Physical Activity. Res Sq 2023:rs.3.rs-2488848. [PMID: 36711885 PMCID: PMC9882674 DOI: 10.21203/rs.3.rs-2488848/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Purpose Exercise program preferences are important for designing physical activity (PA) interventions; yet may change following an intervention. Further, the relationship between preferences and PA behavior change is unclear. This study evaluated exercise program preferences among breast cancer survivors (BCS) before and after a behavioral intervention and associations between program preferences and PA change. Methods BCS were randomized to the BEAT Cancer intervention (n = 110) or written materials (n = 112). Questionnaires assessed exercise program preferences. Minutes per week of moderate-to-vigorous PA (MVPA) were accelerometer-measured and self-reported at baseline (M0), post-intervention (M3), and 3-month follow-up (M6). Results At M0, the majority of intervention group participants preferred exercising with others (62%) yet shifted to preferring exercising alone (59%) at M3 ( p < 0.001). Furthermore, preferring exercising with others at M0 was associated with greater increases in self-reported MVPA between M0 and M6 (124.2 ± 152 vs. 53.1 ± 113.8, p = 0.014). BCS preferring facility-based exercise decreased after the BEAT Cancer intervention (14% vs. 7%, p = 0.039) and preferring exercising at home/had no preference at M0 had greater improvements in accelerometer-measured MVPA from M0 to M3 (74.3 ± 118.8 vs. -2.3 ± 78.4, p = 0.033) and M0 to M6 (44.9 ± 112.8 vs. 9.3 ± 30.4, p = 0.021). Exercise program preferences regarding mode of counseling, training supervision, and type of exercise changed from M0 to M3 but were not associated with changes in MVPA. Conclusion Findings suggest BCS exercise program preferences may change after an intervention and be associated with changes in MVPA. Understanding the role of PA preferences will better inform the design and success of PA behavior change interventions. ClinicTrials.gov, ClinicalTrials.gov number: NCT00929617.
Collapse
|
4
|
Schleicher E, McAuley E, Courneya KS, Anton P, Ehlers DK, Phillips SM, Oster RA, Pekmezi D, Rogers LQ. Moderators of physical activity and quality of life response to a physical activity intervention for breast cancer survivors. Support Care Cancer 2023; 31:53. [PMID: 36526826 DOI: 10.1007/s00520-022-07477-6] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Accepted: 11/09/2022] [Indexed: 12/23/2022]
Abstract
PURPOSE Moderate-to-vigorous physical activity (MVPA) can improve the quality of life (QoL) for breast cancer survivors (BCS), yet, most do not achieve 150 + weekly minutes of MVPA. This study investigated moderators of response to a physical activity (PA) behavior change intervention for BCS. METHODS BCS (N = 222) were randomized to the 3-month intervention (BEAT Cancer) or usual care. Measurements occurred at baseline, post-intervention, and 3 months post-intervention. Measures included accelerometry, self-reported MVPA, and Functional Assessment of Cancer Therapy (FACT-General, FACT-Breast, physical well-being (PWB), social well-being (SWB), emotional well-being (EWB), functional well-being (FWB), additional concerns (AC), and Trial Outcome Index (TOI)). RESULTS Adjusted linear mixed-model analyses indicated individuals ≤ 24 months post-diagnosis and who were single reported smaller increases in weekly self-reported MVPA than those > 24 months (44.07 vs 111.93) and partnered (- 16.24 vs. 49.16 min), all p < 0.05. As for QoL, participants < 12 months post-diagnosis who received chemotherapy experienced smaller improvements than those ≥ 12 months in FACT-General, FACT-Breast, PWB, and SWB scores. Survivors with a history of chemotherapy had smaller improvements in FACT-General, FACT-Breast, PWB, SWB, TOI, and AC scores, all p < 0.05. CONCLUSION These findings indicate that being < 2 years post-diagnosis, single, and prior chemotherapy may limit MVPA and QOL responses to a PA intervention. Further studies are needed to determine if and/or what additional PA supports and resources these subgroups of BCS might find beneficial and effective. TRIAL REGISTRATION ClinicalTrials.gov number: NCT00929617.
Collapse
Affiliation(s)
- Erica Schleicher
- Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.
- O'Neal Comprehensive Cancer Center at the University of Alabama Birmingham (UAB), Birmingham, AL, USA.
| | - Edward McAuley
- Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL, USA
- The Cancer Center at Illinois, Urbana, IL, USA
| | - Kerry S Courneya
- Faculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, AB, Canada
| | - Phillip Anton
- School of Human Sciences, Southern Illinois University Carbondale, Carbondale, IL, USA
| | - Diane K Ehlers
- Department of Quantitative Health Sciences, Mayo Clinic, Phoenix, AZ, USA
| | - Siobhan M Phillips
- Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Robert A Oster
- O'Neal Comprehensive Cancer Center at the University of Alabama Birmingham (UAB), Birmingham, AL, USA
- Department of Medicine, Division of Preventive Medicine, Birmingham, AL, USA
| | - Dorothy Pekmezi
- Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA
- O'Neal Comprehensive Cancer Center at the University of Alabama Birmingham (UAB), Birmingham, AL, USA
| | - Laura Q Rogers
- O'Neal Comprehensive Cancer Center at the University of Alabama Birmingham (UAB), Birmingham, AL, USA
- Department of Medicine, Division of Preventive Medicine, Birmingham, AL, USA
| |
Collapse
|
5
|
Ziauddin M, Schleicher E, Trtik P, Knüpfer L, Skrypnik A, Lappan T, Eckert K, Heitkam S. Comparing wire-mesh sensor with neutron radiography for measurement of liquid fraction in foam. J Phys Condens Matter 2022; 51:015101. [PMID: 36279867 DOI: 10.1088/1361-648x/ac9d16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/06/2022] [Accepted: 10/24/2022] [Indexed: 06/16/2023]
Abstract
The liquid fraction of foam is an important quantity in engineering process control and essential to interpret foam rheology. Established measurement tools for the liquid fraction of foam, such as optical measurement or radiography techniques as well as weighing the foam, are mostly laboratory-based, whereas conductivity-based measurements are limited to the global measurement without detailed spatial information of liquid fraction. In this work, which combines both types of measurement techniques, the conductivity-based wire-mesh sensor is compared with neutron radiography. We found a linear dependency between the liquid fraction of the foam and the wire-mesh readings with a statistical deviation less than 15%. However, the wire-mesh sensor systematically overestimates the liquid fraction, which we attribute to liquid bridge formation between the wires.
Collapse
Affiliation(s)
- M Ziauddin
- Technische Universität Dresden, Institute of Process Engineering and Environmental Technology, 01062 Dresden, Germany
| | - E Schleicher
- Helmholtz-Zentrum Dresden-Rossendorf, Institute of Fluid Dynamics, 01328 Dresden, Germany
| | - P Trtik
- Paul Scherrer Institut, Laboratory for Neutron Scattering and Imaging, 5232 Villigen PSI, Switzerland
| | - L Knüpfer
- Helmholtz-Zentrum Dresden-Rossendorf, Institute of Fluid Dynamics, 01328 Dresden, Germany
| | - A Skrypnik
- Technische Universität Dresden, Institute of Process Engineering and Environmental Technology, 01062 Dresden, Germany
| | - T Lappan
- Helmholtz-Zentrum Dresden-Rossendorf, Institute of Fluid Dynamics, 01328 Dresden, Germany
| | - K Eckert
- Technische Universität Dresden, Institute of Process Engineering and Environmental Technology, 01062 Dresden, Germany
- Helmholtz-Zentrum Dresden-Rossendorf, Institute of Fluid Dynamics, 01328 Dresden, Germany
| | - S Heitkam
- Technische Universität Dresden, Institute of Process Engineering and Environmental Technology, 01062 Dresden, Germany
- Helmholtz-Zentrum Dresden-Rossendorf, Institute of Fluid Dynamics, 01328 Dresden, Germany
| |
Collapse
|
6
|
Williams V, Brown N, Moore JX, Farrell D, Perumean-Chaney S, Schleicher E, Fontaine K, Demark-Wahnefried W, Pekmezi D. Web-Based Lifestyle Interventions for Survivors of Cancer: Usability Study. JMIR Form Res 2022; 6:e30974. [PMID: 35188468 PMCID: PMC8902653 DOI: 10.2196/30974] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2021] [Revised: 10/04/2021] [Accepted: 12/27/2021] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Internet-based lifestyle programs are increasingly being used to deliver health behavior change interventions to survivors of cancer. However, little is known about website use in this population or its association with healthy lifestyle changes. OBJECTIVE The aim of this study is to describe lifestyle intervention website use (log-ins, time on website, and page views) among survivors of cancer and patterns of use by participant characteristics. In addition, associations were explored between website use and changes in healthy lifestyle knowledge and practice. METHODS A total of 35 survivors of cancer were recruited between August 2017 and 2018 to participate in a 2-week, single-arm pilot test of the SurvivorSHINE lifestyle intervention website. Knowledge and practices related to healthy diet and physical activity behaviors were measured at baseline and follow-up. Website use (eg, time spent on the website, frequency of log-ins, and page views) were collected from the SurvivorSHINE administrative site during the intervention period. Patterns of use were examined by participants' gender and race. Correlations between website use and changes in healthy lifestyle knowledge, physical activity, diet, and weight were explored. Mann-Whitney U tests were used to compare demographic factors on website use. RESULTS Participants logged into the SurvivorSHINE intervention website an average of 3.2 (SD 2) times over the 2-week period and spent a total average of 94 (SD 56) minutes viewing the website during the intervention. Examining website activity, 1905 page views were logged. The User Profile (344 page views) and Home sections (301 page views) were the most frequently visited components. No associations were observed between the frequency of log-ins or the total time on the website, improvements in knowledge related to healthy lifestyles, or changes in body weight or dietary intake. However, the total time on the website was positively correlated with improvements in accelerometer-measured physical activity (r=0.74; P=.02) and self-reported physical activity (r=0.35; P=.04). CONCLUSIONS Survivors of cancer demonstrated clear interest in a diet and exercise intervention website, as evidenced by their frequency of log-ins, page views on numerous features, and total viewing time. Moreover, increased website use was correlated with improvements in physical activity.
Collapse
Affiliation(s)
- Victoria Williams
- Department of Health Behavior, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Nashira Brown
- Department of Health Behavior, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Justin Xavier Moore
- Department of Population Health Sciences, Augusta University, Augusta, GA, United States
| | | | - Suzanne Perumean-Chaney
- Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Erica Schleicher
- Department of Health Behavior, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Kevin Fontaine
- Department of Health Behavior, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Wendy Demark-Wahnefried
- Department of Nutritional Sciences, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Dori Pekmezi
- Department of Health Behavior, University of Alabama at Birmingham, Birmingham, AL, United States
| |
Collapse
|
7
|
Thirumalai M, Brown N, Niranjan S, Townsend S, Powell MA, Neal W, Schleicher E, Raparla V, Oster R, Demark-Wahnefried W, Pekmezi D. An Interactive Voice Response System to Increase Physical Activity and Prevent Cancer in the Rural Alabama Black Belt: Design and Usability Study. JMIR Hum Factors 2022; 9:e29494. [PMID: 34982714 PMCID: PMC8767466 DOI: 10.2196/29494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2021] [Revised: 08/29/2021] [Accepted: 09/11/2021] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Increased physical activity (PA) levels are associated with reduced risk and improved survival for several cancers; however, most Americans engage in less than the recommended levels of PA. Using interactive voice response (IVR) systems to provide personalized health education and counseling may represent a high-reach, low-cost strategy for addressing physical inactivity and cancer disparities in disproportionately burdened rural regions. However, there has been a paucity of research conducted in this area to date. OBJECTIVE The aim of this study is to design, develop, and test the usability of an IVR system aimed at increasing PA levels in the rural Alabama Black Belt. METHODS A pilot version of the IVR system was used to assess initial feasibility and acceptability. Detailed exit interviews were conducted to elicit participant feedback, which helped inform the development of a substantially upgraded in-house IVR system. This refined IVR system was then subjected to a sequential explanatory mixed methods evaluation. Participating rural county coordinators and research staff (N=10) tested the usability of the IVR system features for 2 weeks and then completed the System Usability Scale and qualitative semistructured interviews. RESULTS The study sample comprised mostly African American people, women, rural county coordinators, and research staff (N=10). Participants rated the IVR system with a mean score of 81 (SD 5) on the System Usability Scale, implying excellent usability. In total, 5 overarching themes emerged from the qualitative interviews: likes or dislikes of the intervention, barriers to or facilitators of PA, technical difficulties, quality of calls, and suggestions for intervention improvement. Message framing on step feedback, call completion incentives, and incremental goal-setting challenges were areas identified for improvement. The positive areas highlighted in the interviews included the personalized call schedules, flexibility to call in or receive a call, ability to make up for missed calls, narration, and PA tips. CONCLUSIONS The usability testing and feedback received from the rural county coordinators and research staff helped inform a final round of refinement to the IVR system before use in a large randomized controlled trial. This study stresses the importance of usability testing of all digital health interventions and the benefits it can offer to the intervention.
Collapse
Affiliation(s)
- Mohanraj Thirumalai
- Department of Health Services Administration, School of Health Professions, University of Birmingham at Alabama, Birmingham, AL, United States
| | - Nashira Brown
- Department of Nutrition Sciences, School of Health Professions, University of Birmingham at Alabama, Birmingham, AL, United States
| | - Soumya Niranjan
- Department of Health Services Administration, School of Health Professions, University of Birmingham at Alabama, Birmingham, AL, United States
| | - Sh'Nese Townsend
- Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Mary Anne Powell
- Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Whitney Neal
- Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Erica Schleicher
- Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Venkatadri Raparla
- University of Alabama at Birmingham/Lakeshore Research Collaborative, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Robert Oster
- Division of Preventive Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States
| | - Wendy Demark-Wahnefried
- Department of Nutrition Sciences, School of Health Professions, University of Birmingham at Alabama, Birmingham, AL, United States
| | - Dori Pekmezi
- Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States
| |
Collapse
|
8
|
Kanski B, Schleicher E, Doerksen S, Truica C, Cream L, Kass R, Farnan M, Suess R, Gordon B, Hayes M, Zucker D, Schmitz K. Acceptability And Feasibility Of A Tablet Based Supportive Care Platform For Metastatic Breast Cancer Patients. Med Sci Sports Exerc 2021. [DOI: 10.1249/01.mss.0000764848.13762.53] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
9
|
Gordon BR, Schmitz KH, Schleicher E, Doerksen S, Cream L, Kass R, Farnan M, Suess R, Zucker D, Hayes M, Conroy DE. Association Of Step Counts With Symptom Burden In Metastatic Breast Cancer Patients. Med Sci Sports Exerc 2021. [DOI: 10.1249/01.mss.0000764860.48090.98] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
10
|
Schulz J, Jasch K, Scholl S, Mehringer C, Geipel C, Schunk C, Schleicher E, Maćkowiak J, Grünewald M, Bart HJ. Bildoptische Untersuchung von Tropfenmitriss in Boden‐ und Packungskolonnen. CHEM-ING-TECH 2020. [DOI: 10.1002/cite.202055087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- J. Schulz
- Technische Universität Kaiserslautern Lehrstuhl für Thermische Verfahrestechnik Postfach 3049 67653 Kaiserslautern Deutschland
| | - K. Jasch
- Technische Universität Braunschweig Institut für Chemische und Thermische Verfahrenstechnik Universitätsplatz 2 38106 Braunschweig Deutschland
| | - S. Scholl
- Technische Universität Braunschweig Institut für Chemische und Thermische Verfahrenstechnik Universitätsplatz 2 38106 Braunschweig Deutschland
| | - C. Mehringer
- RVT Process Equipment GmbH Paul-Rauschert-Str. 6 96349 Steinwiesen Deutschland
| | - C. Geipel
- RVT Process Equipment GmbH Paul-Rauschert-Str. 6 96349 Steinwiesen Deutschland
| | - C. Schunk
- HZDR Innovation GmbH Bautzner Landstraße 400 01328 Dresden Deutschland
| | - E. Schleicher
- HZDR Innovation GmbH Bautzner Landstraße 400 01328 Dresden Deutschland
| | - J. Maćkowiak
- Envimac Engineering GmbH Im Erlengrund 27 46149 Oberhausen Deutschland
| | - M. Grünewald
- Ruhr-Universität Bochum Lehrstuhl für Fluidverfahrenstechnik Universitätsstr. 150 44801 Bochum Deutschland
| | - H.-J. Bart
- Technische Universität Kaiserslautern Lehrstuhl für Thermische Verfahrestechnik Postfach 3049 67653 Kaiserslautern Deutschland
| |
Collapse
|
11
|
Böckmann KA, von Stumpff A, Bernhard W, Shunova A, Minarski M, Frische B, Warmann S, Schleicher E, Poets CF, Franz AR. Fatty acid composition of adipose tissue at term indicates deficiency of arachidonic and docosahexaenoic acid and excessive linoleic acid supply in preterm infants. Eur J Nutr 2020; 60:861-872. [PMID: 32476053 PMCID: PMC7900037 DOI: 10.1007/s00394-020-02293-2] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2019] [Accepted: 05/21/2020] [Indexed: 11/30/2022]
Abstract
BACKGROUND Arachidonic (ARA) and docosahexaenoic acid (DHA) are constitutive to membrane phospholipids, and essential for brain and overall development. ARA/DHA pools in term infants (TI) are built during the third trimester, stored as adipose tissue triglycerides and predominantly distributed via plasma phosphatidylcholine (PC). In preterm infants (PTI), placental ARA/DHA supply is replaced by linoleic-acid (LA)-enriched nutrition. This study aimed to investigate the impact of PTI nutrition, compared to placental supply, on fatty acid composition in adipose tissue and blood. METHODS Prospective observational study (4/2017-3/2019) in 12 PTI and 3 PTI with enterostomy (PTI/E) (gestational age (GA) < 32 weeks) with surgical intervention at term (± 6 weeks) and 14 TI (GA ≥ 34 weeks, surgical intervention < 2 weeks postnatally). PTI/E were analyzed descriptively only. PC and triglyceride fatty acids were analyzed with tandem mass spectrometry and gas chromatography, respectively. Results were compared between TI and PTI with Wilcoxon Test and shown as median [25th percentile-75th percentile] mol%. RESULTS PTI had less ARA in adipose tissue TG (0.77[0.67-0.87]% vs. 1.04[0.95-1.14]%, p = 0.0003) and plasma PC (20.7[18.7-22.8]% vs. 28.3[22.7-33.5]%, p = 0.011) than TI. PTI also had less DHA in adipose tissue TG (0.6[0.4-0.8]% vs. 1.1[0.8-1.4]%, p = 0.006) and plasma PC (6.4[5.6-7.1]% vs. 8.4[7.8-13.1]%, p = 0.002). LA was increased in PTI's adipose tissue TG (10.0[8.8-12.3]% vs. 3.0[2.5-3.6]%, p < 0.0001) and plasma PC (48.4[44.6-49.6]% vs. 30.6[24.9-35.6]%, p = 0.0002). Similar differences were observed in erythrocyte PC. CONCLUSION In PTI, LA is increased and ARA/DHA decreased in adipose tissue, plasma and erythrocyte lipids as proxies for other tissues, likely caused by PTI nutrition. This may contribute to impaired PTI development.
Collapse
Affiliation(s)
- K A Böckmann
- Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany.
| | - A von Stumpff
- Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany
| | - W Bernhard
- Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany
| | - A Shunova
- Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany
| | - M Minarski
- Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany
| | - B Frische
- Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany
| | - S Warmann
- Department of Pediatric Surgery and Child Urology, Faculty of Medicine, Eberhard-Karls-University, Tübingen, Germany
| | - E Schleicher
- Department of Internal Medicine IV, Faculty of Medicine, Eberhard-Karls-University, Tübingen, Germany
| | - C F Poets
- Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany
| | - A R Franz
- Department of Neonatology, Faculty of Medicine, Eberhard-Karls-University, Calwer Straße 7, 72076, Tübingen, Germany
- Center for Pediatric Clinical Studies, Faculty of Medicine, Eberhard-Karls-University, Tübingen, Germany
| |
Collapse
|
12
|
Kampa-Schittenhelm KM, Haverkamp T, Bonin M, Tsintari V, Bühring HJ, Haeusser L, Blumenstock G, Dreher ST, Ganief T, Akmut F, Illing B, Mau-Holzmann UA, Bonzheim I, Schleicher E, Vogel W, Schittenhelm MM. Epigenetic activation of O-linked β-N-acetylglucosamine transferase overrides the differentiation blockage in acute leukemia. EBioMedicine 2020; 54:102678. [PMID: 32272438 PMCID: PMC7139116 DOI: 10.1016/j.ebiom.2020.102678] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2019] [Revised: 01/29/2020] [Accepted: 01/30/2020] [Indexed: 12/21/2022] Open
Abstract
Background Overriding the differentiation blockage in acute myeloid leukemia (AML) is the most successful mode-of-action in leukemia therapy – now curing the vast majority of patients with acute promyelocytic leukemia (APL) using all-trans retinoic acid (ATRA)-based regimens. Similar approaches in other leukemia subtypes, such as IDH1/2-mutated AML, are under active investigation. We herein present successful release of the differentiation blockage upon treatment with the natural (−)-Δ9-Tetrahydrocannabinol isomer dronabinol in vitro and in vivo. Methods Cellular maturation and differentiation were followed in two patients employing whole genome methylation profiling, proteome analyses, NGS deep sequencing and multispectral imaging flow cytometry. For functional studies lentiviral OGT knock-down in vitro and ex vivo cell models were created to evaluate proliferative, apoptotic and differentiating effects of OGT in acute leukemia. Findings In here, we provide molecular evidence that dronbinol is capable to override the differentiation blockage of acute leukemia blasts at the state of the leukemia-initiating clone. We further identify the O-linked β-N-acetyl glucosamine (O-GlcNAc) transferase (OGT) to be crucial in this process. OGT is a master regulator enzyme adding O-GlcNAc to serine or threonine residues in a multitude of target proteins. Aberrant O-GlcNAc modification is implicated in pathologies of metabolic, neurodegenerative and autoimme diseases as well as cancers. We provide evidence that dronabinol induces transcription of OGT via epigenetic hypomethylation of the transcription start site (TSS). A lentiviral OGT-knock out approach proves the central role of OGT exerting antileukemic efficacy via a dual-mechanism of action: High concentrations of dronabinol result in induction of apoptosis, whereas lower concentrations drive cellular maturation. Most intriguingly, overriding of the differentiation blockage of acute leukemia blasts is validated in vivo following two patients treated with dronabinol. Interpretation In conclusion, we provide evidence for overcoming the differentiation blockage in acute leukemia in subentities beyond promyelocytic and IDH1/2-mutated leukemia and thereby identify O-GlcNAcylation as a novel (drugable) field for future leukemia research. Funding Unrestricted grant support by the IZKF Program of the Medical Faculty Tübingen (MMS) and Brigitte Schlieben-Lange Program as well as the Margarete von Wrangell Program of the Ministry of Science, Research and the Arts, Baden-Württemberg, Germany (KKS) and Athene Program of the excellence initiative University of Tübingen (KKS).
Collapse
Affiliation(s)
- K M Kampa-Schittenhelm
- University Hospital Tübingen, Dept. of Hematology, Oncology, clinical Immunology and Rheumatology, Otfried-Müller-Straße 10, BB West, Rooms 585-587, 72076 Tübingen, Germany.
| | | | - M Bonin
- Microarray Genechip Facility Tübingen and Institute for Medical Genetics and Applied Genomics, Germany
| | - V Tsintari
- University Hospital Tübingen, Dept. of Hematology, Oncology, clinical Immunology and Rheumatology, Otfried-Müller-Straße 10, BB West, Rooms 585-587, 72076 Tübingen, Germany
| | - H J Bühring
- University Hospital Tübingen, Dept. of Hematology, Oncology, clinical Immunology and Rheumatology, Otfried-Müller-Straße 10, BB West, Rooms 585-587, 72076 Tübingen, Germany
| | - L Haeusser
- University Hospital Tübingen, Dept. of Hematology, Oncology, clinical Immunology and Rheumatology, Otfried-Müller-Straße 10, BB West, Rooms 585-587, 72076 Tübingen, Germany
| | - G Blumenstock
- Institute of Clinical Epidemiology and Applied Biometry, Eberhard Karls University Tübingen, Germany
| | - S T Dreher
- University Hospital Tübingen, Dept. of Hematology, Oncology, clinical Immunology and Rheumatology, Otfried-Müller-Straße 10, BB West, Rooms 585-587, 72076 Tübingen, Germany
| | - T Ganief
- Proteome Center Tübingen at the University of Tübingen, Germany
| | - F Akmut
- University Hospital Tübingen, Dept. of Hematology, Oncology, clinical Immunology and Rheumatology, Otfried-Müller-Straße 10, BB West, Rooms 585-587, 72076 Tübingen, Germany
| | - B Illing
- University Hospital Tübingen, Dept. of Hematology, Oncology, clinical Immunology and Rheumatology, Otfried-Müller-Straße 10, BB West, Rooms 585-587, 72076 Tübingen, Germany
| | - U A Mau-Holzmann
- University Hospital Tübingen, Division of Cytogenetics, Institute for Medical Genetics and Applied Genomics, Germany
| | - I Bonzheim
- Institute of Pathology at the University Hospital Tübingen, Germany
| | - E Schleicher
- University Hospital Tübingen, Dept. of Diabetology, Endokrinology, Nephrology, Germany
| | - W Vogel
- University Hospital Tübingen, Dept. of Hematology, Oncology, clinical Immunology and Rheumatology, Otfried-Müller-Straße 10, BB West, Rooms 585-587, 72076 Tübingen, Germany
| | - M M Schittenhelm
- University Hospital Tübingen, Dept. of Hematology, Oncology, clinical Immunology and Rheumatology, Otfried-Müller-Straße 10, BB West, Rooms 585-587, 72076 Tübingen, Germany; Clinic of Medical Oncology and Hematology, Cantonal Hospital St. Gallen (KSSG), Switzerland
| |
Collapse
|
13
|
Schmitz KH, Zhang X, Winkels R, Schleicher E, Mathis K, Doerksen S, Cream L, Rosenberg J, Kass R, Farnan M, Halpin-Murphy P, Suess R, Zucker D, Hayes M. Developing "Nurse AMIE": A tablet-based supportive care intervention for women with metastatic breast cancer. Psychooncology 2019; 29:232-236. [PMID: 31762104 DOI: 10.1002/pon.5301] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2019] [Revised: 11/13/2019] [Accepted: 11/14/2019] [Indexed: 11/07/2022]
Affiliation(s)
- Kathryn H Schmitz
- Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania
| | | | - Renate Winkels
- Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania
| | - Erica Schleicher
- Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania
| | - Katlynn Mathis
- Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania
| | - Shawna Doerksen
- Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania
| | - Leah Cream
- Department of Hematology Oncology, Penn State College of Medicine, Hershey, Pennsylvania
| | - Jennifer Rosenberg
- Department of Radiation Oncology, Penn State College of Medicine, Hershey, Pennsylvania
| | - Rena Kass
- Department of Surgery, Penn State College of Medicine, Hershey, Pennsylvania
| | - Michelle Farnan
- Palliative Care, Penn State College of Medicine, Hershey, Pennsylvania
| | | | - Robin Suess
- Department of Hematology Oncology, Penn State College of Medicine, Hershey, Pennsylvania
| | - David Zucker
- Physical Medicine and Rehabilitation, Swedish Cancer Institute, Seattle, Washington
| | - Michael Hayes
- Department of Psychiatry, Penn State College of Medicine, Hershey, Pennsylvania
| |
Collapse
|
14
|
Koeppel M, Wiskemann J, Schleicher E, Kass RB, Schmitz KH. Impact Of Prehabilitation In Oncology Via Exercise - Breast Cancer: The Improve-B Study. Med Sci Sports Exerc 2019. [DOI: 10.1249/01.mss.0000561207.43983.fe] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
15
|
Schleicher E, Potiaumpai M, Taylor K, Moyer J, Burse N, Schmitz K. Exercise During Chemotherapy And Its Effects On Symptom Management: Enact: Exercise In All Chemotherapy. Med Sci Sports Exerc 2019. [DOI: 10.1249/01.mss.0000561230.04011.a2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
16
|
Potiaumpai M, Schleicher E, Taylor KG, Moyer J, Burse N, Schmitz K. Exercise during Chemotherapy Improves Physical Function: Findings from EnACT: Exercise in All Chemotherapy. Med Sci Sports Exerc 2019. [DOI: 10.1249/01.mss.0000561232.88762.97] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
17
|
Schleicher E, Cream L, Kass R, Farnan M, Zhang X, Mathis K, Moyer J, Schmitz K. Nurse Amie (Addressing Metastatic Individuals Everyday). Med Sci Sports Exerc 2018. [DOI: 10.1249/01.mss.0000538776.16249.d4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
18
|
Didangelos T, Schleicher E, Kantartzis K. Role of lipids in the pathophysiology of peripheral and autonomic neuropathy and cardiac function in patients with diabetes mellitus type 1. A preliminary report. Hippokratia 2018; 22:92. [PMID: 31217683 PMCID: PMC6548523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Affiliation(s)
- T Didangelos
- 1 Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece
| | - E Schleicher
- Department of Internal Medicine IV, Division of Endocrinology, Diabetology, Angiology, Nephrology und Clinical Chemistry, University of Tübingen, Tübingen, Germany
- Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard-Karls-University of Tübingen, Tübingen, Germany
- German Center for Diabetes Research (DZD), Tübingen, Germany
| | - K Kantartzis
- Department of Internal Medicine IV, Division of Endocrinology, Diabetology, Angiology, Nephrology und Clinical Chemistry, University of Tübingen, Tübingen, Germany
- Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard-Karls-University of Tübingen, Tübingen, Germany
- German Center for Diabetes Research (DZD), Tübingen, Germany
| |
Collapse
|
19
|
Siegel-Axel D, Jaghutriz BA, Peter A, Machann J, Kovarova M, Ullrich S, Gerst F, Nadalin S, Sipos B, Königsrainer A, Schick F, Stefan N, Fend F, Haen S, Häring HU, Wagner R, Schleicher E. Human fat depots show distinct quantitative, qualitative and functional inter-individual differences. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1641835] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- D Siegel-Axel
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - BA Jaghutriz
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - A Peter
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - J Machann
- Sektion für Experimentelle Radiologie, Abteilung für Diagnostische und Interventionelle Radiologie, Radiologische Klinik, Tübingen, Germany
- Institut für Diabetes-Forschung und Metabolische Erkrankungen (IDM) – Metabolic Imaging des Helmholtz-Zentrums München an der Universität Tübingen, Neuherberg, Germany
| | - M Kovarova
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - S Ullrich
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - F Gerst
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - S Nadalin
- Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum (UKT), Tübingen, Germany
| | - B Sipos
- Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum (UKT), Tübingen, Germany
| | - A Königsrainer
- Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum (UKT), Tübingen, Germany
| | - F Schick
- Sektion für Experimentelle Radiologie, Abteilung für Diagnostische und Interventionelle Radiologie, Radiologische Klinik, Tübingen, Germany
| | - N Stefan
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - F Fend
- Institut für Pathologie und Neuropathologie, Abt. für Allgemeine und Molekulare Pathologie und Pathologische Anatomie, Tübingen, Germany
| | - S Haen
- Institut für Pathologie und Neuropathologie, Abt. für Allgemeine und Molekulare Pathologie und Pathologische Anatomie, Tübingen, Germany
| | - HU Häring
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - R Wagner
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - E Schleicher
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| |
Collapse
|
20
|
Wagner R, Machann J, Guthoff M, Nawroth PP, Nadalin S, Saleem MA, Heyne N, Königsrainer A, Fend F, Schick F, Fritsche A, Stefan N, Häring HU, Schleicher E, Siegel-Axel DI. The protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine fetuin-A. Sci Rep 2017; 7:2261. [PMID: 28536464 PMCID: PMC5442123 DOI: 10.1038/s41598-017-02210-4] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2017] [Accepted: 04/06/2017] [Indexed: 02/06/2023] Open
Abstract
Renal sinus fat (RSF) is a perivascular fat compartment located around renal arteries. In this in vitro and in vivo study we hypothesized that the hepatokine fetuin-A may impair renal function in non alcoholic fatty liver disease (NAFLD) by altering inflammatory signalling in RSF. To study effects of the crosstalk between fetuin-A, RSF and kidney, human renal sinus fat cells (RSFC) were isolated and cocultured with human endothelial cells (EC) or podocytes (PO). RSFC caused downregulation of proinflammatory and upregulation of regenerative factors in cocultured EC and PO, indicating a protective influence of RFSC. However, fetuin-A inverted these benign effects of RSFC from an anti- to a proinflammatory status. RSF was quantified by magnetic resonance imaging and liver fat content by 1H-MR spectroscopy in 449 individuals at risk for type 2 diabetes. Impaired renal function was determined via urinary albumin/creatinine-ratio (uACR). RSF did not correlate with uACR in subjects without NAFLD (n = 212, p = 0.94), but correlated positively in subjects with NAFLD (n = 105, p = 0.0005). Estimated glomerular filtration rate (eGRF) was inversely correlated with RSF, suggesting lower eGFR for subjects with higher RSF (r = 0.24, p < 0.0001). In conclusion, our data suggest that in the presence of NAFLD elevated fetuin-A levels may impair renal function by RSF-induced proinflammatory signalling in glomerular cells.
Collapse
Affiliation(s)
- R Wagner
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - J Machann
- Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany.,Department of Diagnostic and Interventional Radiology, Section on Experimental Radiology, University Hospital Tübingen, Tübingen, Germany
| | - M Guthoff
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany
| | - P P Nawroth
- German Center for Diabetes Research (DZD), Neuherberg, Germany.,Department Medicine I and Clinical Chemistry, University of Heidelberg, Heidelberg, Germany
| | - S Nadalin
- Department of General, Visceral and Transplant Surgery, University of Tübingen, Comprehensive Cancer Center, Tübingen, Germany
| | - M A Saleem
- Bristol Renal and Children's Renal Unit, School of Clinical Sciences, University of Bristol, Bristol, UK
| | - N Heyne
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany
| | - A Königsrainer
- Department of General, Visceral and Transplant Surgery, University of Tübingen, Comprehensive Cancer Center, Tübingen, Germany
| | - F Fend
- Institute of Pathology and Neuropathology, University of Tübingen, Tübingen, Germany
| | - F Schick
- Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany.,Department of Diagnostic and Interventional Radiology, Section on Experimental Radiology, University Hospital Tübingen, Tübingen, Germany
| | - A Fritsche
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - N Stefan
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - H-U Häring
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - E Schleicher
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - D I Siegel-Axel
- Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany. .,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard Karls University Tübingen, Tübingen, Germany. .,German Center for Diabetes Research (DZD), Neuherberg, Germany.
| |
Collapse
|
21
|
Wagner R, Machann J, Guthoff M, Nadalin S, Nawroth P, Saleem MA, Stefan N, Schick F, Fend F, Fritsche A, Königsrainer A, Heyne N, Häring HU, Schleicher E, Siegel-Axel DI. Die ‚fettige Niere‘: Interaktionen von renalem Sinusfett mit der Fettleber beeinflussen die Zytokinexpression glomerulärer Zellen in vitro und die renale Funktion in Prädiabetikern. DIABETOL STOFFWECHS 2017. [DOI: 10.1055/s-0037-1601608] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- R Wagner
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - J Machann
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
| | - M Guthoff
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - S Nadalin
- Universitätsklinik für Allgemeine, Viszeral- und Transplantationschirurgie (AVT), Tübingen, Germany
| | - P Nawroth
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Neuherberg/München, Germany
| | - MA Saleem
- Bristol Royal Hospital for Children, Paediatric Renal Medicine, University of Bristol, Bristol, Germany
| | - N Stefan
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - F Schick
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
| | - F Fend
- Institut für Pathologie und Neuropathologie (Department), Allgemeine Pathologie und Pathologische Anatomie, Tübingen, Germany
| | - A Fritsche
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - A Königsrainer
- Universitätsklinik für Allgemeine, Viszeral- und Transplantationschirurgie (AVT), Tübingen, Germany
| | - N Heyne
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - HU Häring
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - E Schleicher
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - DI Siegel-Axel
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| |
Collapse
|
22
|
Jovancevic N, Dendorfer A, Matzkies M, Kovarova M, Heckmann JC, Osterloh M, Boehm M, Weber L, Nguemo F, Semmler J, Hescheler J, Milting H, Schleicher E, Gelis L, Hatt H. Medium-chain fatty acids modulate myocardial function via a cardiac odorant receptor. Basic Res Cardiol 2017; 112:13. [PMID: 28116519 PMCID: PMC5258789 DOI: 10.1007/s00395-017-0600-y] [Citation(s) in RCA: 62] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/29/2016] [Accepted: 01/03/2017] [Indexed: 12/17/2022]
Abstract
Several studies have demonstrated the expression of odorant receptors (OR) in various human tissues and their involvement in different physiological and pathophysiological processes. However, the functional role of ORs in the human heart is still unclear. Here, we firstly report the functional characterization of an OR in the human heart. Initial next-generation sequencing analysis revealed the OR expression pattern in the adult and fetal human heart and identified the fatty acid-sensing OR51E1 as the most highly expressed OR in both cardiac development stages. An extensive characterization of the OR51E1 ligand profile by luciferase reporter gene activation assay identified 2-ethylhexanoic acid as a receptor antagonist and various structurally related fatty acids as novel OR51E1 ligands, some of which were detected at receptor-activating concentrations in plasma and epicardial adipose tissue. Functional investigation of the endogenous receptor was carried out by Ca2+ imaging of human stem cell-derived cardiomyocytes. Application of OR51E1 ligands induced negative chronotropic effects that depended on activation of the OR. OR51E1 activation also provoked a negative inotropic action in cardiac trabeculae and slice preparations of human explanted ventricles. These findings indicate that OR51E1 may play a role as metabolic regulator of cardiac function.
Collapse
Affiliation(s)
- Nikolina Jovancevic
- Department of Cell Physiology, Ruhr-University Bochum, 44801, Bochum, Germany.
| | - A Dendorfer
- Walter Brendel Centre of Experimental Medicine, Ludwig-Maximilians-University, 80336, Munich, Germany.,DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
| | - M Matzkies
- Institute for Neurophysiology, University of Cologne, 50931, Cologne, Germany
| | - M Kovarova
- Division of Pathobiochemistry and Clinical Chemistry, University of Tuebingen, 72076, Tuebingen, Germany
| | - J C Heckmann
- Department of Cell Physiology, Ruhr-University Bochum, 44801, Bochum, Germany
| | - M Osterloh
- Department of Cell Physiology, Ruhr-University Bochum, 44801, Bochum, Germany
| | - M Boehm
- Department of Cell Physiology, Ruhr-University Bochum, 44801, Bochum, Germany
| | - L Weber
- Department of Cell Physiology, Ruhr-University Bochum, 44801, Bochum, Germany
| | - F Nguemo
- Institute for Neurophysiology, University of Cologne, 50931, Cologne, Germany
| | - J Semmler
- Institute for Neurophysiology, University of Cologne, 50931, Cologne, Germany
| | - J Hescheler
- Institute for Neurophysiology, University of Cologne, 50931, Cologne, Germany
| | - H Milting
- Erich and Hanna Klessmann Institute, Clinic for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Ruhr-University Bochum, 32545, Bad Oeynhausen, Germany
| | - E Schleicher
- Division of Pathobiochemistry and Clinical Chemistry, University of Tuebingen, 72076, Tuebingen, Germany
| | - L Gelis
- Department of Cell Physiology, Ruhr-University Bochum, 44801, Bochum, Germany
| | - H Hatt
- Department of Cell Physiology, Ruhr-University Bochum, 44801, Bochum, Germany
| |
Collapse
|
23
|
Kiss SZ, Rostas AM, Heidinger L, Spengler N, Meissner MV, MacKinnon N, Schleicher E, Weber S, Korvink JG. A microwave resonator integrated on a polymer microfluidic chip. J Magn Reson 2016; 270:169-175. [PMID: 27497077 DOI: 10.1016/j.jmr.2016.07.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/09/2016] [Revised: 07/16/2016] [Accepted: 07/18/2016] [Indexed: 06/06/2023]
Abstract
We describe a novel stacked split-ring type microwave (MW) resonator that is integrated into a 10mm by 10mm sized microfluidic chip. A straightforward and scalable batch fabrication process renders the chip suitable for single-use applications. The resonator volume can be conveniently loaded with liquid sample via microfluidic channels patterned into the mid layer of the chip. The proposed MW resonator offers an alternative solution for compact in-field measurements, such as low-field magnetic resonance (MR) experiments requiring convenient sample exchange. A microstrip line was used to inductively couple MWs into the resonator. We characterised the proposed resonator topology by electromagnetic (EM) field simulations, a field perturbation method, as well as by return loss measurements. Electron paramagnetic resonance (EPR) spectra at X-band frequencies were recorded, revealing an electron-spin sensitivity of 3.7·10(11)spins·Hz(-1/2)G(-1) for a single EPR transition. Preliminary time-resolved EPR experiments on light-induced triplet states in pentacene were performed to estimate the MW conversion efficiency of the resonator.
Collapse
Affiliation(s)
- S Z Kiss
- Institute of Microstructure Technology (IMT), Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany.
| | - A M Rostas
- Institute of Physical Chemistry (IPC), University of Freiburg, Albertstr. 21, 79104 Freiburg, Germany
| | - L Heidinger
- Institute of Physical Chemistry (IPC), University of Freiburg, Albertstr. 21, 79104 Freiburg, Germany
| | - N Spengler
- Institute of Microstructure Technology (IMT), Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany
| | - M V Meissner
- Institute of Microstructure Technology (IMT), Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany
| | - N MacKinnon
- Institute of Microstructure Technology (IMT), Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany
| | - E Schleicher
- Institute of Physical Chemistry (IPC), University of Freiburg, Albertstr. 21, 79104 Freiburg, Germany
| | - S Weber
- Institute of Physical Chemistry (IPC), University of Freiburg, Albertstr. 21, 79104 Freiburg, Germany
| | - J G Korvink
- Institute of Microstructure Technology (IMT), Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany
| |
Collapse
|
24
|
Kovarova M, Königsrainer I, Königsrainer A, Machicao F, Häring HU, Schleicher E, Peter A. The genetic variant I148 M in PNPLA3 is associated with increased hepatic retinyl-palmitate storage in humans. DIABETOL STOFFWECHS 2016. [DOI: 10.1055/s-0036-1580902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
25
|
Kerner W, Freckmann G, Müller U, Roth J, Schleicher E, Niederau C, Müller-Wieland D, Landgraf R, Heinemann L. Positionspapier der Kommission für Labordiagnostik in der Diabetologie der DGKL und der DDG. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0041-109081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- W. Kerner
- Direktor der Klinik für Diabetes und Stoffwechselkrankheiten, Klinikum Karlsburg der Klinikgruppe Dr. Guth GmbH & Co. KG, Karlsburg
| | - G. Freckmann
- Management, Institut für Diabetes-Technologie, Ulm
| | - U. Müller
- Klinik für Innere Medizin, Klinikum der Friedrich-Schiller-Universität Jena
| | - J. Roth
- Klinik für Innere Medizin, Klinikum der Friedrich-Schiller-Universität Jena
| | - E. Schleicher
- FB Endokrinologie und Stoffwechselkrankheiten, Klinik für Innere Medizin III, Universitätsklinikum Jena
| | | | | | - R. Landgraf
- Beauftragter des Vorstands, Deutsche Diabetes Stiftung, München
| | | |
Collapse
|
26
|
Madzima TA, Schleicher E, Ormsbee MJ, Moffatt R, Panton LB. Resistance Training and Protein Supplementation on Muscular Strength and Body Composition in Breast Cancer Survivors. Med Sci Sports Exerc 2015. [DOI: 10.1249/01.mss.0000478481.92050.07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
27
|
Siegel-Axel DI, Guthoff M, Nadalin S, Schmidt U, Schreiner B, Wagner R, Königsrainer A, Nawroth P, Heyne N, Schleicher E, Häring HU. Humane perihiläre Fettzellen und das Hepatokin Fetuin-A beeinflussen die Expression von Adhäsionsmolekülen, Zyokinen und Chemokinen in co-kultivierten Endothelzellen: Ein Mechanismus zur Anlockung von Makrophagen in der Pathogenese der Niere? DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
28
|
Kovarova M, Machicao FE, Stefan N, Häring HU, Peter A, Schleicher E, Randrianarisoa E. Assoziation von individuellen freien Fettsäuren im Plasma und der Intima-Media-Dicke. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549694] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
29
|
Fleming T, Schleicher E, Häring HU, Nawroth PP. Overexpression of the glucose transporter 1 in renal mesangial cells protects against cellular stress via Nrf2/NQO1. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549577] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
30
|
Bauer RV, Sulaj A, Kopf S, Gröne E, Gröne HJ, Hoffmann S, Schleicher E, Häring HU, Schwenger V, Herzig S, Nawroth PP, Fleming T. Loss of ALCAM/CD166 partially protects against diabetic nephropathy. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
31
|
Klingler C, Wolf M, Suhm T, Li J, Chen S, Zhao X, Schleicher E, Häring HU, Xu G, Lehmann R, Weigert C. Lysophosphatidylcholine als Regulatoren der Genexpression humaner Skelettmuskelzellen. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1374897] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
32
|
Kender Z, Fleming T, Kopf S, Torzsa P, Grolmusz V, Herzig S, Schleicher E, Rácz K, Reismann P, Nawroth P. Effect of Metformin on Methylglyoxal Metabolism in Patients with Type 2 Diabetes. Exp Clin Endocrinol Diabetes 2014; 122:316-9. [DOI: 10.1055/s-0034-1371818] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- Z. Kender
- 2nd Department of Medicine, Semmelweis University, Budapest, Hungary
| | - T. Fleming
- Department of Internal Medicine I and Clinical Chemistry, University of Heidelberg, Heidelberg, Germany
| | - S. Kopf
- Department of Internal Medicine I and Clinical Chemistry, University of Heidelberg, Heidelberg, Germany
| | - P. Torzsa
- Department of Family Medicine, Semmelweis University, Budapest, Hungary
| | - V. Grolmusz
- 2nd Department of Medicine, Semmelweis University, Budapest, Hungary
| | - S. Herzig
- Joint Research Division, Molecular Metabolic Control, German Cancer Research Center DKFZ, Network Aging Research, ZMBH, Heidelberg, Germany
| | - E. Schleicher
- Division of Clinical Chemistry/Central Laboratory, Department of Internal Medicine, University of Tubingen, Tubingen, Germany
| | - K. Rácz
- 2nd Department of Medicine, Semmelweis University, Budapest, Hungary
| | - P. Reismann
- 2nd Department of Medicine, Semmelweis University, Budapest, Hungary
| | - P. Nawroth
- Department of Internal Medicine I and Clinical Chemistry, University of Heidelberg, Heidelberg, Germany
| |
Collapse
|
33
|
Peter A, Kovarova M, Königsrainer A, Machicao F, Stefan N, Häring HU, Schleicher E. The I148 M variant in PNPLA3 is associated with altered hepatic lipid composition in humans. Exp Clin Endocrinol Diabetes 2014. [DOI: 10.1055/s-0034-1372076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
34
|
Drescher A, Hoene M, Häring HU, Schleicher E, Weigert C. Bedeutung des MAPK Signalweges für die Genexpression und die metabolische Anpassung während Ausdauersports in Leber und Muskel. DIABETOL STOFFWECHS 2013. [DOI: 10.1055/s-0033-1341744] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
35
|
Klingler C, Wolf M, Suhm T, Li J, Chen S, Zhao X, Schleicher E, Häring HU, Xu G, Lehmann R, Weigert C. Lysophosphatidylcholine sind Mediatoren der Lipotoxizität in humanen Skelettmuskelzellen. DIABETOL STOFFWECHS 2013. [DOI: 10.1055/s-0033-1341720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
36
|
Nerlich A, Haraida S, Hagedorn H, Wiest I, Schreiner M, Schleicher E. Morphological aspects of basement-membranes and their receptors in benign and malignant neoplasms (review). Int J Oncol 2012; 6:1193-202. [PMID: 21556658 DOI: 10.3892/ijo.6.6.1193] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
We review the current knowledge on alterations of the major basement membrane (BM) components and their cellular integrin receptors in benign and malignant tumors of epithelial and mesenchymal origin. While benign tumors usually exhibit a continous BM, recent analyses provide evidence that invasive growth of carcinomas coincides with (a) a loss in a proper BM, (b) changes in the type of integrin receptor expression and (c) the retained ability of certain tumor cells to synthesize matrix components. This latter aspect has been regarded as a potentially beneficial 'host' mechanism against invasive growth. This assumption is strongly supported by the finding of a positive correlation between the extent of BM loss and both a lesser degree of tumor differentiation and a worse prognosis of tumor growth. The resulting concept indicates that in carcinomas an imbalance in the cell-matrix interaction is the leading element in invasive growth. In mesenchymal tumors a somewhat different role of the BM can be observed. Thus, the qualitative and quantitative expression of major BM components in benign mesenchymal tumors closely relates to the BM pattern of normal tissues providing a histogenetically oriented classification of benign mesenchymal tumors. Most well-differentiated sarcomas retain a BM pattern close to that of the histogenetically related tissue, although in poorly differentiated sarcomas no such attribution to a histogenetic orientation of the tumor cells can be found.
Collapse
Affiliation(s)
- A Nerlich
- UNIV MUNICH,KLINIKUM GROSSHADERN,HNO KRANKE KLIN & POLIKLIN,D-81377 MUNICH,GERMANY. STADT KRANKENHAUS,INST DIABET FORSCH,D-80804 MUNICH,GERMANY
| | | | | | | | | | | |
Collapse
|
37
|
Hoene M, Chen S, Li J, Schleicher E, Häring HU, Xu G, Weigert C, Lehmann R. 13C-labelled palmitate and metabolomics/lipidomics analyses reveal the fate of free fatty acids in fasting mice. DIABETOL STOFFWECHS 2012. [DOI: 10.1055/s-0032-1314780] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
38
|
Wagner R, Machann J, Lehmann R, Rittig K, Schick F, Lenhart J, Artunc F, Linder K, Claussen CD, Schleicher E, Fritsche A, Häring HU, Weyrich P. Exercise-induced albuminuria is associated with perivascular renal sinus fat in individuals at increased risk of type 2 diabetes. Diabetologia 2012; 55:2054-8. [PMID: 22526613 DOI: 10.1007/s00125-012-2551-z] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/27/2011] [Accepted: 03/15/2012] [Indexed: 10/28/2022]
Abstract
AIMS/HYPOTHESIS Microalbuminuria represents an established surrogate marker of early diabetic nephropathy and glomerular microangiopathy. Increasing evidence is emerging of a role of perivascular adipose tissue (PVAT) as an important link between obesity, insulin resistance and both macro- and microangiopathy. It is not known whether perivascular renal sinus fat (RSF) has an impact on microalbuminuria in the prediabetic stage. We investigated whether RSF quantified by MRI is associated with microalbuminuria before or after exercise. METHODS Non-diabetic individuals at increased risk of type 2 diabetes were recruited into the Tübingen Lifestyle Intervention Program (TULIP); 146 participants took part in the analysis. RSF was measured in axial MRI sections at the level of the renal artery. Urine was collected before and after exercise stress testing. RESULTS Participants (age 47 ± 12 years; mean ± SD) reached a mean exercise load of 176 ± 49 W, with a mean arterial peak pressure (MAPP) of 112 ± 14 mmHg. After adjusting for sex, age, visceral adipose tissue (VAT) and MAPP during exercise, RSF was significantly associated with postexercise albumin/creatinine ratio (ACR; p = 0.006). No association between RSF and baseline BP could be observed after adjusting for confounders (p = 0.26), and there was no association between RSF and baseline ACR either (p = 0.2). CONCLUSIONS RSF is associated with exercise-induced albuminuria independently of sex, age, VAT and MAPP in a non-diabetic cohort at diabetic risk. We conclude that PVAT in the renal sinus may play a role in the pathogenesis of microalbuminuria.
Collapse
Affiliation(s)
- R Wagner
- Department of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, Eberhard Karls University Tübingen, Otfried-Müller-Str 10, 72076 Tübingen, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Wagner R, Machann J, Rittig K, Schick F, Lenhart J, Artunc F, Linder K, Fritsche A, Lehmann R, Schleicher E, Häring HU, Weyrich P. Perivaskuläres Nierensinusfett assoziiert mit belastungsinduzierter Albuminurie in Patienten mit erhöhtem Typ 2 Diabetesrisiko. DIABETOL STOFFWECHS 2012. [DOI: 10.1055/s-0032-1314586] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
40
|
Rettig I, Schleicher E. Labormethoden bei Diabetes mellitus. DIABETOL STOFFWECHS 2012. [DOI: 10.1055/s-0031-1283990] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
41
|
Tschritter O, Preissl H, Hennige AM, Sartorius T, Stingl KT, Heni M, Ketterer C, Stefan N, Machann J, Schleicher E, Fritsche A, Häring HU. High cerebral insulin sensitivity is associated with loss of body fat during lifestyle intervention. Diabetologia 2012; 55:175-82. [PMID: 21927893 DOI: 10.1007/s00125-011-2309-z] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/13/2011] [Accepted: 08/18/2011] [Indexed: 01/17/2023]
Abstract
AIMS/HYPOTHESIS Loss of weight and body fat are major targets in lifestyle interventions to prevent diabetes. In the brain, insulin modulates eating behaviour and weight control, resulting in a negative energy balance. This study aimed to test whether cerebral insulin sensitivity facilitates reduction of body weight and body fat by lifestyle intervention in humans. METHODS The study was performed as an additional arm of the TUebingen Lifestyle Intervention Program (TULIP). In 28 non-diabetic individuals (14 female/14 male; mean ± SE age 42 ± 2 years; mean ± SE BMI 29.9 ± 0.8 kg/m²), we measured cerebrocortical insulin sensitivity by using magnetoencephalography before lifestyle intervention. Total and visceral fat were measured by using MRI at baseline and after 9 months and 2 years of lifestyle intervention. RESULTS Insulin-stimulated cerebrocortical theta activity at baseline correlated with a reduction in total adipose tissue (r = -0.59, p = 0.014) and visceral adipose tissue (r = -0.76, p = 0.001) after 9 months of lifestyle intervention, accompanied by a statistical trend for reduction in body weight change (r = -0.37, p = 0.069). Similar results were obtained after 2 years. CONCLUSIONS/INTERPRETATION Our results suggest that high insulin sensitivity of the human brain facilitates loss of body weight and body fat during lifestyle intervention.
Collapse
Affiliation(s)
- O Tschritter
- Department of Internal Medicine IV, University Hospital, University of Tübingen, Otfried-Müller-Str. 10, 72076 Tübingen, Germany.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Bernhard W, Gille C, Schleicher E, Stichtenoth G, Perez-Gil J, Griese M, Pynn CJ, Poets CF. Regulation und potentielle Bedeutung lipidomischer Surfactantveränderungen bei Mensch und Versuchstier. Pneumologie 2011. [DOI: 10.1055/s-0031-1296096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
43
|
Montonen J, Boeing H, Schleicher E, Fritsche A, Pischon T. Association of changes in body mass index during earlier adulthood and later adulthood with circulating obesity biomarker concentrations in middle-aged men and women. Diabetologia 2011; 54:1676-83. [PMID: 21468642 DOI: 10.1007/s00125-011-2124-6] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/23/2010] [Accepted: 02/21/2011] [Indexed: 12/13/2022]
Abstract
AIMS/HYPOTHESIS The objective of our study was to investigate whether changes in BMI during earlier adulthood are more strongly associated with levels of circulating obesity biomarkers in middle age than are BMI changes during later adulthood. METHODS The study included 1,612 participants from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. The associations of BMI changes based on recalled BMI for the age ranges 25-40 years (earlier adulthood) and 40-55 years (later adulthood) with later biomarker levels were compared using a linear model, adjusted for BMI at age 25 years and conventional risk factors. RESULTS BMI changes during both time periods as well as BMI at age 25 years were significantly associated with circulating levels of adiponectin, γ-glutamyltransferase (GGT), alanine aminotransferase (ALT), high-sensitivity C-reactive protein (hs-CRP) and HDL-cholesterol (HDL-C) in both sexes, and of HbA(1c) in women. However, BMI gain for the age range 25-40 years was significantly more strongly associated with unfavourable levels of adiponectin, hs-CRP, HDL-C and HbA(1c) in men and women, and of GGT and ALT in men (p difference <0.05) than BMI gain for the age range 40-55 years. The percentage change in biomarker levels per unit gain in BMI for the age range 25-40 years ranged from 0.81% (HbA(1c)) to 9.80% (hs-CRP) in men, and from 0.75% (HbA(1c)) to 14.7% (hs-CRP) in women, whereas for the age range 40-55 years, values ranged from -0.15% to 4.82% in men and from 0.25% to 7.06% in women. CONCLUSIONS/INTERPRETATION The results support the hypothesis that an increase in BMI in earlier adulthood is more strongly associated with unfavourable circulating levels of obesity biomarkers later in life than is an increase in BMI in later adulthood.
Collapse
Affiliation(s)
- J Montonen
- Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany.
| | | | | | | | | |
Collapse
|
44
|
Silbernagel G, Kovarova M, Cegan A, Machann J, Unmuth S, Schick F, Stefan N, Häring HU, Schleicher E, Fritsche A, Peter A. Dis-coordinated activation of de novo lipogenesis and stearoyl-CoA desaturase by monosaccharides determines liver fat accumulation in humans. DIABETOL STOFFWECHS 2011. [DOI: 10.1055/s-0031-1277376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
45
|
Peter A, Fritsche A, Stefan N, Heni M, Häring HU, Schleicher E. Diagnostic value of hemoglobin A1c for type 2 diabetes mellitus in a population at risk. Exp Clin Endocrinol Diabetes 2011; 119:234-7. [PMID: 21264802 DOI: 10.1055/s-0030-1270440] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
OBJECTIVE Because the American Diabetes Association has recently included HbA1c as the primary diagnostic test for the detection of diabetes mellitus (HbA1c ≥6.5%) we investigated its use as screening parameter for diabetes in a cohort at increased risk for the disease. RESEARCH DESIGN AND METHODS During the last 10 years 2 036 Caucasians at risk to develop type 2 diabetes but not having this diagnosis yet, consecutively underwent a 75 g oral glucose tolerance test (OGTT). HbA1c was determined with the HPLC method (Tosoh A1c 2.2), external and internal quality controls were well within the allowed ranges. RESULTS The oral glucose tolerance test classified 1 523 individuals as normal glucose tolerant (NGT), 387 as impaired glucose tolerant (IGT) or having impaired fasting glycemia (IFG) and 126 as diabetic. The 6.5% cut-off value of HbA1c classified 47% of the diabetic individuals correctly. Of the remaining 53% diabetic individuals (HbA1c <6.5%) 35% had increased fasting glucose levels, while 65% were only diagnosed by their increased 2 h glucose values. CONCLUSION A cut-off value of 6.5% HbA1c classifies diabetic subjects with a specificity of 98.7%. However, the sensitivity of 46.8% is low, indicating that more than half of diabetic subjects are missed when using this test. The present data shows that the use of HbA1c as a the primary diagnostic test will reduce diabetes prevalence. Furthermore, it suggests, that HbA1c and OGTT measurements cannot simply be exchanged, but most probably detect and define different categories of diabetes, i. e., categories with different risk of cardiovascular disease.
Collapse
Affiliation(s)
- A Peter
- Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Medicine, Nephrology and Clinical Chemistry, University of Tübingen, Germany.
| | | | | | | | | | | |
Collapse
|
46
|
Schleicher E, Jesinghaus M, Hildebrandt G, Liebrecht K, Hampel U, Freyer R. Optischer Labortomograph für die Lehre und Forschung. BIOMED ENG-BIOMED TE 2009. [DOI: 10.1515/bmte.1998.43.s1.480] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
47
|
Schleicher E, Hampel U, Freyer R. DIAGNOSTIK VON HODENERKRANKUNGEN MIT FUNKTIONELLER NIRDIAGNOSTIK UND OPTISCHER STREULICHTTOMOGRAPHIE. BIOMED ENG-BIOMED TE 2009. [DOI: 10.1515/bmte.2000.45.s1.507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
48
|
Schleicher E. [Average blood glucose instead of HbA1c?]. MMW Fortschr Med 2009; 151:45-47. [PMID: 19739524 DOI: 10.1007/bf03365799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Affiliation(s)
- E Schleicher
- Leiter der Abteilung für Klinische Chemie am Universitäts-klinikum Tübingen.
| |
Collapse
|
49
|
Nauck M, Schleicher E, Müller-Wieland D. HbA1c – neue Eichung / neue Einheiten. DIABETOL STOFFWECHS 2009. [DOI: 10.1055/s-0028-1098912] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
50
|
Peter A, Weigert C, Staiger H, Machicao F, Schick F, Machann J, Stefan N, Thamer C, Häring HU, Schleicher E. Individual stearoyl-CoA desaturase 1 (SCD1) expression modulates ER stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. DIABETOL STOFFWECHS 2009. [DOI: 10.1055/s-0029-1221993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|